sumatriptan · Tonix Meds · NDA 210884
Tosymra
Earliest generic entry, as listed
19 Jul 2031
Blocked by patent: US 9211282.
Listed patents · 6 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 9211282 | product, use U-1719 | 19 Jul 2031 |
| US 10603305 | product, use U-1719 | 16 Jun 2030 |
| US 11337962 | product, use U-1719 | 16 Jun 2030 |
| US 12090139 | product | 16 Jun 2030 |
| US 9610280 | product, use U-1719 | 16 Jun 2030 |
| US 9974770 | product, use U-1719 | 16 Jun 2030 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 210884 · 001 · RLD | spray, nasal | 10MG/SPRAY | 19 Jul 2031 |
Expired or delisted (3)
- US 8268791 · product · 9 May 2026
- US 8440631 · product, use U-1719 · 9 May 2026
- US 9283280 · product · 9 May 2026